The trypanosomatid metabolite N',N5-bis-(glutathionyl)spermidine (trypanothione) has been demonstrated to form a stable adduct with the aromatic arsenical drug melarsen oxide [p-(4,6-diamino-s-triazinyl-2-yl)aminophenyl arsenoxide]. The stability constant of the melarsen-trypanothione adduct (Mel T) has been determined to be 1.05 x 107 M-1. When bloodstream Trypanosoma brucei are incubated with either melarsen oxide or the 2,3-dimercaptopropanol adduct of melarsen oxide (melarsoprol), Mel T is the only arsenical derivative detectable in acid-soluble extracts of the cells. Trypanothione may therefore be regarded as a primary target for aromatic arsenical derivatives against African trypanosomes. The selective toxic action of these compounds might arise through sequestration of intracellular trypanothione in the form of Mel T, or Mel T itself may be toxic within the cell. The latter possibility is illustrated by the finding that Mel T is an inhibitor of trypanothione reductase from T. brucei (K; = 9.0 ,uM)-an enzyme that is central to the regulation of the thiol/disulfide redox balance in the parasite and absent from the host.
from the host.
The development of antimicrobial arsenical drugs stems from the pioneering studies on chemotherapy conducted by Paul Ehrlich and his colleagues in the early part of this century. In most clinical situations, the use of such compounds has, for some time, been superseded by the development of more selective agents. However, in the absence of suitable atternatives, the melaminyl aromatic arsenicals remain the drugs of choice for the treatment of late-stage African trypanosomiasis (sleeping sickness) (1) . The bloodstream form of the African trypanosome is extremely sensitive to trivalent aromatic arsenicals. On exposure to the drug melarsen oxide [p-(4,6-diamino-s-triazinyl-2-yl)aminophenyl arsenoxide], these organisms rapidly lose their motility and cell lysis soon follows. A number of theories have been put forward to account for these effects and for some years the prevailing view has been that the extreme toxicity of trivalent arsenicals toward African trypanosomes may be attributed to inhibition of parasite pyruvate kinase (2) . As this organism lacks both functional oxidative phosphorylation and tricarboxylic acid cycle and depends entirely on glycolysis for ATP generation (3) , it was believed to be uniquely sensitive to such an effect. However, more recent studies indicate that inhibition of glycolysis is secondary to the lytic effect of melarsen oxide and is not the result of primary inhibition of pyruvate kinase (4) . Thus, despite >80 years of research, the mode of action of trypanocidal arsenicals remains completely unknown.
As early as 1909, Ehrlich himself proposed that trivalent arsenicals might be active by virtue of their ability to react with cellular sulfhydryl groups essential to parasite survival. The discovery that trypanosomatids contain the dithiol me-
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HPLC Analysis. Thiols and arsenical derivatives were separated by ion-paired reverse-phase HPLC on a HewlettPackard HP1090 fitted with a Beckman-Altex C18 column. Compounds were detected by UV absorbance or by fluorescence following postcolumn derivatization with fluorescamine. Elution systems and methods have been described (7) .
Mass Spectrometric and Amino Acid Analysis. Amino acid analysis of the adduct of melarsen oxide with dihydrotrypanothione (Mel T) was performed as described (5) . Mel Exposure of T. brucei to Arsenical Drugs. Bloodstream trypomastigote forms of T. brucei (EATRO 427, clone 118) were grown in 300-to 400-g rats as described (7). Purified trypanosomes were resuspended (2 x 106 ml-') in 60 mM sodium phosphate buffer (pH 8.0) containing 44 mM NaCl, 50 mM glucose, and bovine serum albumin (1 mg/ml). Aliquots (10 ml) were incubated at 25TC for 5 min before the addition of melarsen oxide (10 ,uM) or Mel B (50 or 75 AM). At intervals, 5 ml of 10 mM glutathione was added to terminate uptake of the drug and the cells were immediately pelleted by centrifugation. The trypanosomes were resuspended and washed once in 1.5 ml of60 mM sodium phosphate buffer, pH 8 .0/44 mM NaCl/50 mM glucose and then centrifuged. The resulting pellet was extracted with 1.0 ml of cold 5% trichloroacetic acid containing 0.01 M HCl. Following centrifugation, the supernatant was extracted with ethyl acetate (5 x 2 vol), dried under reduced pressure, and redissolved in 20% (vol/vol) propylene glycol for HPLC analysis.
Trypanothione Reductase Assays. Trypanothione disulfide [Try(S)2] reductase from Crithidiafasciculata was purified as described (9) ; partially purified enzyme (6.6 units/ml) from T. brucei was obtained by modification of this procedure. Activity was measured spectrophotometrically at 340 nm at 25°C in 0.1 M Hepes buffer (pH 7.8) containing 1 moiety had been replaced by diaminooctane (10), only one dithioarsane product was formed. Affminty of Trypanothione and Other Thiols for Melarsen Oxide. The reaction of melarsen oxide with T(SH)2 and other thiols was followed spectrophotometrically by monitoring the conversion of melarsen oxide (Amax = 272 nm) to the corresponding dithio-melarsen adducts (Amax = 283 nm). By calculating difference spectra, as described in the previous section, the amount of adduct formed with increasing thiol concentration could be determined. Fig. 3 clearly discernible in the concentrated cell extracts after 5 min; it then increased to a maximum of 0.1 nmol per 108 cells after 15 min and decreased thereafter. No free melarsen oxide could be detected in the extracts. Although microscopic examination 30 min after addition of drug showed that =5Q% ofthe cells had become swollen and nonmotile, it is likely that the bulk of the intracellular Try(SH)2 remained intact. This is supported by the recovery of unreacted Try(SH)2 on addition of excess melarsen oxide to the concentrated extract (Fig. 5,  30-min control) . In the same experiment intracelluiar GSH and Try(SH)2 concentrations were determined to be 2.57 + 0.02 and 0.91 ± 0.09 nmol per 108 cells [0.43 mM and 0.16 mM, assuming 108 cells have a volume of 5.8 ,.l (11) ], respectively. Thus the intracellular concentration of Mel T reached 17 ,.M, accounting for 10% of the intracellular Try(SH)2, before cell lysis commenced. Mel T was also formed when intact bloodstream forms of T. brucei were exposed to Mel B. Following a 30-min exposure to 50 and 75 /.M Mel B, 0.7% and 2.6%, respectively, of the intracellular Try(SH)2 had been converted to Mel T (not shown). Neither Mel B nor free melarsen oxide could be detected in the cell extracts, suggesting that exchange between 2,3-dimercaptopropanol and Try(S14)2 was occurring within the cell.
Inhibition of Try(S)2 Reductase by Mel T. Mel T was shown to be an effective inhibitor of Try(S)2 reductase purified from either C. fasciculata or T. brucei. Both enzymes were inhibited competitively with respect to Try(S)2 with Ki values of 36 ,uM and 9 ,M for C. fasciculata and T. brucei, respectively ( Fig. 6 A and B) . In the same series of experiments the Km for Try(S)2 for the T. brucei enzyme was determined to be 58 AM, similar to the reported value of 53 ,M for the enzyme from C. fasciculata (9) .
DISCUSSION
The glutathione-spermidine conjugate trypanothione is the principal intracellular thiol of T. brucei and other trypanosomatids, accounting for >68% of the intracellular glutathione (12) . Unlike mammalian cells, trypanosomes do not possess classical glutathione reductase or glutathione peroxidase activities. Instead, these vital enzymes have been replaced by isofunctional trypanothione-dependent counterparts (9, 13) . Trivalent arsenical derivatives are known to form stable complexes with enzymes, coenzymes, or other compounds that contain two or more proximal thiol groups (14) . For this reason we investigated the possibility that trypanothione and/or the trypanothione-dependent enzymes might be involved in the trypanocidal action of arsenical drugs. The data presented here indicate that trivalent melaminyl arsenical drugs become concentrated within bloodstream forms of T. brucei in the form of a macrocyclic dithioarsane adduct with trypanothione. This derivative, Mel T, can be isolated and is considerably more stable than the corresponding adduct that might be formed by the other major thiol species of the cell, glutathione and cysteine. In light of this information, it is necessary to reevaluate currently held theories that relate to the selective toxic effects of aromatic arsenical drugs on African trypanosomes. Two aspects of the problem may be considered separately-namely, the mode of entry of the drug and its site of action.
Trypanosomes are thought to concentrate melarsen oxide against a concentration gradient (15), but it is not known whether this occurs by simple diffusion or by a membranemediated process. In either event, the present experiments suggest that melarsen oxide will complex with trypanothione to form Mel T on entry to the cell and, assuming that Mel T will not readily diffuse across cell membrane, drug exit will be prevented. The importance of this effect is illustrated by the fact that Mel T is also formed in vivo when the organisms are exposed to the dimercaptopropanol adduct of melarsen a pronounced synergism between the trypanocidal activity of aromatic arsenical drugs and the ornithine decarboxylase inhibitor difluoromethylornithine (DFMO) (16, 17) . DFMO selectively blocks the biosynthesis of spermidine and hence trypanothione in trypanosomes (7). Thus, DFMO-induced depletion of trypanothione and its concomitant sequestration by melaminyl arsenical drugs offers an explanation of the synergism between these apparently unrelated compounds.
